JOHN BEDNAR: Open Payments
NPI 1720373905 · RANDALLSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 22 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $173 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $66 |
| Novo Nordisk Inc | 3 | $64 |
| SANOFI-AVENTIS U.S. LLC | 2 | $52 |
| Dexcom, Inc. | 2 | $52 |
| Abbott Laboratories | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| Antares Pharma, Inc. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: TZIELD, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, INSPIRE, ELIQUIS, XYOSTED, GARDASIL 9, XIFAXAN.
Industry payments across MD — which companies pay providers there.
